Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
17.75
+0.09 (0.51%)
At close: May 20, 2025, 4:00 PM
17.82
+0.07 (0.39%)
After-hours: May 20, 2025, 6:39 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $1.73 billion as of May 20, 2025. Its market cap has decreased by -4.06% in one year.
Market Cap
1.73B
Enterprise Value
668.56M
1-Year Change
-4.06%
Ranking
Category
Stock Price
$17.75
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $1.73B, an increase of 427.60%. That is a compound annual growth rate of 36.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 1.72B | -12.81% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.67B |
| Johnson & Johnson | 368.49B |
| AbbVie | 327.97B |
| Novo Nordisk | 293.82B |
| UnitedHealth Group | 286.15B |
| Abbott Laboratories | 235.82B |
| Novartis AG | 215.48B |
| AstraZeneca | 214.95B |